Dyspnoea management in acute coronary syndrome patients treated with ticagrelor - Wikidata - wikimedia - TriplyDB

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

http://www.wikidata.org/entity/Q27006816

about

Switching between ticagrelor and clopidogrel in patients who underwent percutaneous coronary intervention: insight into contemporary practice in Chinese patients Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials.Dyspnea in patients treated with P2Y12 receptor antagonists: insights from the GReek AntiPlatElet (GRAPE) registry.Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in Taiwan.Real-world incidence of patient-reported dyspnoea with ticagrelor

P2860

Q33646807-7EEC49A3-1595-4B6B-9075-4DD0FA09A262 Q37039218-96A0A9A9-47F5-460B-9ABE-204D3528A360 Q38817051-4EF71A0F-27B3-4C19-95C9-D3A3E304744A Q38984860-6BB19F36-8C0C-4CC7-BC50-408C264C03E7 Q48761201-ADD0DC2C-FC19-4F77-AA38-05A992CB867E Q54944304-7C5B1C12-7EF7-4DDE-A1D6-F6DAB04FFD40 Q57134527-BF5F4265-95EB-457E-9A22-801244E740EB

P2860

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

http://www.wikidata.org/entity/Q27006816

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

@ast

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

@en

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

@nl

type

label

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

@ast

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

@en

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

@nl

prefLabel

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

@ast

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

@en

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

@nl

P1433

Q27006816-1DA9275C-E62B-4D05-8E92-942B15A8F8E0

P1476

Q27006816-385B1F09-FF9D-4D1C-AC55-5AC9B6897D53

P2093

Q27006816-6088E5D6-0901-4960-8A8E-36A4F8BFF5E3

Q27006816-DE848181-0D49-4434-8915-D34389E78250

P275

Q27006816-83356081-BB8F-470D-B41A-13BBE4AC7778

P2860

Q27006816-0E78FC85-482A-4EE8-8C5F-AFA54209FC9B

Q27006816-105E23EB-171B-4623-B92B-B2B4B976C860

Q27006816-4DB5C7EF-A5B5-43DE-ACB0-D260CB8B3878

Q27006816-50AD4DDE-9550-496B-826D-24EDCF61D857

Q27006816-640B4B9B-B477-40B9-805A-626AE034BCAF

Q27006816-65C73908-547C-47B3-81EB-FBDA792C2A6A

Q27006816-66A7E728-F2CF-4E27-B3A8-3EBE0AD12FD4

Q27006816-ADAF0AB5-B2E9-4721-BB5B-15BEA6FC35AD

Q27006816-AF585873-D109-4A43-BC26-5960F637A501

Q27006816-B70821DD-FE3F-48A8-90A9-9BFFD975C7F5

P304

Q27006816-C4B0B2A3-80C4-43A9-948A-C8FA5B4840EA

P31

Q27006816-E90461E1-45D6-4A5F-AF3F-8C91173D5B93

P3181

Q27006816-0810C577-F95F-4FC9-9999-A7C70EEDA265

P356

Q27006816-938FF7FB-F9C7-4649-8F49-D247CFBDE030

P407

Q27006816-5AF4770A-B458-4A54-BE26-E6AB7481F02B

P433

Q27006816-7A102FC2-4B06-4EF0-8EA6-3D7DF58B0C3F

P478

Q27006816-2F1E205C-02D6-4A43-B097-C8BA48907092

P50

Q27006816-4E9608EF-7920-4DA6-AFEF-3F1A270FB03A

Q27006816-75FAB95B-479D-40CE-B954-4C045229C03C

P577

Q27006816-89A2E06B-6693-4F6D-844D-23F4B5316179

P5875

Q27006816-46A0200A-E474-4570-9E94-E6D5BAFA8296

P698

Q27006816-3EA6552E-0FC3-4CDB-93DC-FD29C11E7EDD

P921

Q27006816-B6A659F2-B4A5-46B2-989C-EC666F0123C7

Q27006816-DC56F06A-CF82-4456-91F9-396CF048C4B7

P932

Q27006816-3FB40400-DC6F-49C8-A803-85347BA2D3E8

P3181

P356

2048872614554108

P1433

European heart journal. Acute cardiovascular care

P1476

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

@en

P2093

G. Parodi

http://www.w3.org/2001/XMLSchema#string

R. F. Storey

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events.

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.

Are there symptom differences in patients with coronary artery disease presenting to the ED ultimately diagnosed with or without ACS?

High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.

Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study.

Switching acute coronary syndrome patients from prasugrel to clopidogrel.

Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trial.

P304

555-560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1921418

http://www.w3.org/2001/XMLSchema#string

P356

10.1177/2048872614554108

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Robert F. Storey

P577

2014-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266324322

http://www.w3.org/2001/XMLSchema#string

P698

25267878

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

mechanism of action

P932

4657388

http://www.w3.org/2001/XMLSchema#string